Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
In subjects with T2DM who have inadequate glycemic control on maximally or near-maximally effective doses of metformin and on sitagliptin, after 26 weeks of treatment: •To assess the effect of canagliflozin relative to placebo on HbA1c •To assess the safety and tolerability of canagliflozin
Critère d'inclusion
- Type 2 Diabetes Mellitus With Inadequate Glycemic Control